Small pupils present a significant challenge for the cataract surgeon, requiring excellent intraoperative decision making to maximize the likelihood of a successful outcome. One of the common causes of small pupils, intraoperative floppy iris syndrome (IFIS), in particular increases the likelihood of complications such as posterior capsule rupture and iris trauma. Fortunately, a variety of pharmacologic and mechanical strategies are available to help maintain an adequately dilated pupil to increase the likelihood of successful, safe cataract surgery.
IFIS was first described in association with current or prior tamsulosin (Flomax ® , Boehringer Ingelheim, Ingelheim am Rhein, Germany; Ridgefield, CT, US) use in 2005. 1 Besides poor preoperative pupil dilation, severe IFIS exhibits a triad of intraoperative signs: (1) iris billowing and floppiness, (2) iris prolapse to the incisions, and (3) progressive intraoperative miosis ( Figure 1 ). However, there is a wide range of clinical severity. IFIS can be graded as mild (good dilation; some iris billowing without prolapse or constriction), moderate (iris billowing with some constriction of a moderately dilated pupil), or severe. 2 In a prospective study of 167 eyes in patients taking tamsulosin, 10% had no IFIS, 17% mild IFIS, 30%
moderate IFIS, and 43% severe IFIS. 2 Poor preoperative pupil dilation and iris billowing during instillation of intracameral lidocaine are predictive of greater IFIS severity. [2] [3] [4] [5] Numerous studies have confirmed that unexpected IFIS increases the rate of cataract surgical complications. 2, 3, [6] [7] [8] [9] A retrospective study of nearly 100,000 surgeries in male patients with cataracts reported a two-fold increase in the rate of serious postoperative complications including retinal detachment, retained nuclear fragments, and severe inflammation in patients taking tamsulosin. 6 IFIS has since been documented with other systemic alpha-1 antagonists such as doxazosin (Cardura ® , Pfizer, New York, NY, US), terazosin (Hytrin ® , Abbott, Chicago, IL, US), and alfuzosin (Uroxatral ® , Sanofi
Aventis, Paris, France), all of which are non-selective alpha-1 antagonists. 3 A number of retrospective and prospective studies have also shown that the frequency and severity of IFIS is much higher with tamsulosin than non-selective alpha-1 antagonists. 3, 4, [6] [7] [8] 10, 11 Silodosin (Rapaflo ® , Allergan, Irvine, CA, US)
is a systemic selective alpha-1A blocker that is similar to tamsulosin in its strong propensity to cause IFIS. Ophthalmologists should also know that Jalyn ® (GlaxoSmithKline, Brentford, UK) is the brand name for the combination of dutasteride and tamsulosin.
The surgeon should assess the quality of dilation during the presurgical examination, but a careful history is also important to reduce the likelihood of unexpected intraoperative miosis. In fact, even female patients are now treated with tamsulosin for urinary problems. 12 Unfortunately, stopping tamsulosin preoperatively is of questionable value. 2 Preoperative counseling with high-risk patients should occur to discuss the risk of IFIS and subsequent iris and pupil changes.
Intracameral injection of alpha agonists such as phenylephrine or epinephrine, as first reported by
Gurbaxani & Packard and Shugar, respectively, is a safe and inexpensive strategy for IFIS ( Figure  2) . 13 is a 5-0 polypropylene single use device that is introduced with a disposable injector (Figure 3 ). 20 The way in which the iris drapes over the sides of the device creates a round 6.25 mm or 7 mm pupil diameter. 21 The greater rigidity makes 4-0 retractors more durable and easier to manipulate.
Before initiating the capsulorrhexis, 1 mm limbal paracenteses are created in each quadrant, including a separate stab incision just posterior to the temporal clear corneal incision in a diamond configuration as originally advocated by Oetting and Omphroy. 22 Alternatively, a 25 or 26 gauge needle can be used to make tracts for the hooks. 22, 23 Use of tamsulosin continues to increase in the cataract population, but ophthalmologists can continue to deliver great results thanks to awareness of each patient's risk for IFIS and familiarity with a few of these surgical management techniques. 
